Healthcare major Abbott on Wednesday said it has launched next-generation heart rhythm management devices in India.
The company has introduced its new Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronisation Therapy Defibrillator (CRT-D) devices for people with abnormal heart rhythms and heart failure, the drug major said in a statement.
The devices offer new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications, it added.
Additional benefits include a patient preferred design, improved battery longevity and MRI compatibility, Abbott said.
"The positive impact of remote monitoring has been proven repeatedly and leads to better patient outcomes," Abbott's Cardiac Rhythm Management business divisional vice president and chief medical officer Avi Fischer said.
The devices provide people the ability to connect to their doctor anytime, even while away from home, and reinforces its commitment to incorporate advanced technologies that will help improve engagement between patients, caregivers and doctors, he added.
Abbott employs over one lakh people in more than 160 countries. The company employs around 12,000 people in India.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU